TABLE 2.
Patient characteristics and claims‐based diagnoses, drugs, and medical procedures for patients diagnosed with stroke
| Number of patients (%) | |||
|---|---|---|---|
| Ischemic | Hemorrhagic (not ischemic) | ||
| Total | 116 (100%) | 77 (100%) | |
| Sex | Female | 50 (43.1%) | 33 (42.9%) |
| Male | 66 (56.9%) | 44 (57.1%) | |
| Age | Mean (SD) | 66.8 (13.1) | 68.1 (13.9) |
| Diagnoses | Cerebral infarction | 19 (16.4%) | — |
| Cerebral hemorrhage + Cerebral infarction | 13 (11.2%) | — | |
| Cerebellar infarction | 8 (6.9%) | — | |
| Subarachnoid hemorrhage + Cerebral infarction | 6 (5.2%) | — | |
| Cerebral hemorrhage | — | 21 (27.3%) | |
| Subarachnoid hemorrhage | — | 17 (22.1%) | |
| Chronic subdural hematoma | — | 13 (16.9%) | |
| Putamen hemorrhage | — | 6 (7.8%) | |
| Subcortical hemorrhage | — | 6 (7.8%) | |
| Others | 70 (60.3%) | 14 (18.2%) | |
| Drugs | No Drug | 39 (33.6%) | 37 (48.1%) |
| Warfarin potassium | 12 (10.3%) | 9 (11.7%) | |
| Clopidogrel sulfate | 10 (8.6%) | 4 (5.2%) | |
| Cilostazol | 5 (4.3%) | 5 (6.5%) | |
| Aspirin | 9 (7.8%) | — | |
| Aspirin + warfarin potassium | 3 (2.6%) | 4 (5.2%) | |
| Others | 38 (32.8%) | 18 (23.4%) | |
| Medical procedures | MRI/CT | 33 (28.4%) | 26 (33.8%) |
| MRI/CT + Rehab + US | 22 (19.0%) | 9 (11.7%) | |
| MRI/CT + Rehab | 4 (3.4%) | 19 (24.7%) | |
| MRI/CT + Rehab + Hosp | 12 (10.3%) | 5 (6.5%) | |
| MRI/CT + Rehab + US + Hosp | 11 (9.5%) | 6 (7.8%) | |
| MRI/CT + US | 12 (10.3%) | 3 (3.9%) | |
| No procedure | 11 (9.5%) | 1 (1.3%) | |
| MRI/CT + Hosp | 3 (2.6%) | 5 (6.5%) | |
| MRI/CT + US + Hosp | 4 (3.4%) | 2 (2.6%) | |
| US | 3 (2.6%) | — | |
| Rehab | 1 (0.9%) | — | |
| Rehab + Hosp | — | 1 (1.3%) | |
Abbreviations: CT, computed tomography; Hosp, hospitalization MRI, magnetic resonance imaging; Rehab, rehabilitation; SD, standard deviation; US, ultrasonography.